TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07790237: Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Anti-aging Efficacy and Skin Radiance-enhancing Effect of Dermial®.

Sponsor: Bioiberica · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 146 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$8,256,000

Rescue Site Savings

+$5,443,800

Unlock Full NCT07790237 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07790237 Rescue Dossier →